NanoGroup S.A.’s acquisition of bridge financing.

NanoGroup S.A.’s acquisition of bridge financing.

NanoGroup S.A.’s acquisition of bridge financing.

The Management Board of NanoGroup S.A. has received offers from investors interested in acquiring series L shares issued (on the basis of the resoluti…

Conclusion of an investment agreement by NanoGroup S.A.

Conclusion of an investment agreement by NanoGroup S.A.

NanoGroup S.A. has entered into an agreement with eCapital sp. z o.o., based in Warsaw (Investor), an investment agreement. The Investment Agreement s…

New Player in the family of shareholders of NanoGroup S.A.

New Player in the family of shareholders of NanoGroup S.A.

March 25, 2024. Members of the Board received a notice from Mr. Michał Lach pursuant to Art. 69 para. 1 of the Act on Public Offering, Conditions…

The first publication from the Polepi project in 2024.

The first publication from the Polepi project in 2024.

In January 2024, the first publication from the Polepi project was released.“Nanoparticle-Encapsulated Epirubicin Efficacy in the Inhibition of …

Three organs are still not a crowd, as the NanoSanguis SA perfusionist team jokes

Three organs are still not a crowd, as the NanoSanguis SA perfusionist team jokes

In addition to the kidneys and liver, the innovative NanOx system also works well in heart perfusion, as proven by a recent study …

Successful liver perfusion another step in the development of NanoSanguis SA’s innovative perfusion system

Successful liver perfusion another step in the development of NanoSanguis SA’s innovative perfusion system

The conducted pig liver perfusion is another step taken by the company to introduce an innovative organ perfusion system to the Polish market. Na…

pp-thumbnail